Mark McHale, Ph.D.
Mark McHale, Ph.D. is Chief Scientific Officer of Oak Hill Bio. Most recently, Dr. McHale co-founded Aslan Pharmaceuticals and served as its Chief Development Officer and Head of R&D. He has also held leadership positions with AstraZeneca and SmithKline Beecham (now GlaxoSmithKline Plc.).